Amneal Completes Kashiv Takeover
Bolsters Capabilities In Complex Generics And 505(b)(2) Hybrid Drugs
Executive Summary
Amneal says it has taken the latest step towards “Amneal 2.0” after completing its deal to acquire Kashiv Specialty Pharmaceuticals.